Kulkarni Sandeep Chidambar 4
4 · Tourmaline Bio, Inc. · Filed Oct 24, 2025
Insider Transaction Report
Form 4
Kulkarni Sandeep Chidambar
DirectorCEO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-10-22−25,316→ 503,478 totalExercise: $7.90Exp: 2033-06-17→ Common Stock (25,316 underlying) - Exercise/Conversion
Common Stock
2025-10-22$7.90/sh+25,316$199,996→ 755,051 total
Holdings
- 7,000(indirect: By Gilead Capital, LP)
Common Stock
Footnotes (2)
- [F1]These shares are held by Gilead Capital, LP ("Gilead"). The Reporting Person's spouse is a partner of Gilead and shares voting and investment power with respect to the shares held by Gilead, and therefore the Reporting Person may be deemed an indirect beneficial owner of these shares. This report is not an admission that the Reporting Person is an indirect beneficial owner of these shares for purposes of Section 16 or for any other purpose.
- [F2]The shares subject to the option vested as to 25% of the shares on June 14, 2024 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.